APO-Bortezomib bortezomib 3.5mg powder for injection vial

Ország: Ausztrália

Nyelv: angol

Forrás: Department of Health (Therapeutic Goods Administration)

Aktív összetevők:

bortezomib, Quantity: 3.5 mg

Beszerezhető a:

Arrotex Pharmaceuticals Pty Ltd

INN (nemzetközi neve):

Bortezomib

Gyógyszerészeti forma:

Injection, powder for

Összetétel:

Excipient Ingredients: mannitol

Az alkalmazás módja:

Subcutaneous, Intravenous

db csomag:

1

Recept típusa:

(S4) Prescription Only Medicine

Terápiás javallatok:

Bortezomib, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy.,Bortezomib, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma.,Bortezomib is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy and who have progressive disease.

Termék összefoglaló:

Visual Identification: White to off-white powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Engedélyezési státusz:

Licence status A

Engedély dátuma:

2015-07-22